Systems Oncology to Present at Upcoming Scientific and Investor Conferences

Systems Oncology to Present at Upcoming Scientific and Investor Conferences




Systems Oncology to Present at Upcoming Scientific and Investor Conferences

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Systems Oncology LLC, a privately held biopharmaceutical company developing a new class of multi-modal RNA therapeutics, announced today that the management team will be presenting and participating at the following upcoming conferences:

H.C. Wainwright 23rd Annual Global Investment Conference
Company Presentation

Presented by Dr. Spyro Mousses, CEO

September 10th, 2021, 3:00pm ET

Virtual

Wells Fargo 2021 Virtual Healthcare Conference

Fireside Chat

Presented by Dr. Spyro Mousses, CEO

September 10th, 2021, 4:00pm ET

Virtual

TIDES USA Conference

Arromer – Receptor Directed Delivery for Ultra-precise RNAi Multi-targeting

Presented by Dr. Spyro Mousses, CEO

September 23rd, 2021, 12:20pm ET

Boston, MA

Archived replays of the webcasts following each event will be available on Systems Oncology’s website at https://www.systemsoncology.com/news-and-events/

About Systems Oncology:

Systems Oncology is developing a new class of multimodal RNA therapeutics that simultaneously silence the right combination of disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our Arromer platform is used to digitally engineer and rapidly produce self-delivering therapeutics which are directed to specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of drug products in oncology, yet our multimodal RNA therapeutics platform can be harnessed to transform outcomes for any complex polygenic disease.

Contacts

Company & Investors:
Andrew Matricaria, CFO

andrew@systemsoncology.com
(312) 952-3451

Media:
Courtney Villani

CVillani@systemsoncology.com
(619) 807-1467